Home
/
QUEST DIAGNOSTICS INC
/
Financials
/
Quarterly
QUEST DIAGNOSTICS INC — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that QUEST DIAGNOSTICS INC filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$2.82B
Oct 21, 2025
Q2
2025
Jun 30, 2025
$2.76B
Jul 23, 2025
Q1
2025
Mar 31, 2025
$2.65B
Apr 23, 2025
Q3
2025
Sep 30, 2024
$2.49B
Oct 21, 2025
Q2
2025
Jun 30, 2024
$2.40B
Jul 23, 2025
Q1
2025
Mar 31, 2024
$2.37B
Apr 23, 2025
Q3
2024
Sep 30, 2023
$2.30B
Oct 23, 2024
Q2
2024
Jun 30, 2023
$2.34B
Jul 24, 2024
Q1
2024
Mar 31, 2023
$2.33B
Apr 24, 2024
Q3
2023
Sep 30, 2022
$2.49B
Oct 25, 2023
Q2
2023
Jun 30, 2022
$2.45B
Jul 27, 2023
Q1
2023
Mar 31, 2022
$2.61B
Apr 28, 2023
Q3
2022
Sep 30, 2021
$2.77B
Oct 21, 2022
Q2
2022
Jun 30, 2021
$2.55B
Jul 22, 2022
Q1
2022
Mar 31, 2021
$2.72B
Apr 22, 2022
Q3
2021
Sep 30, 2020
$2.79B
Oct 22, 2021
Q2
2021
Jun 30, 2020
$1.83B
Jul 23, 2021
Q1
2021
Mar 31, 2020
$1.82B
Apr 23, 2021
Q3
2020
Sep 30, 2019
$1.96B
Oct 23, 2020
Q2
2020
Jun 30, 2019
$1.95B
Jul 24, 2020
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2019
Mar 31, 2019
$1.89B
Apr 24, 2019
Q3
2018
Sep 30, 2018
$1.89B
Oct 24, 2018
Q2
2018
Jun 30, 2018
$1.92B
Jul 25, 2018
Q1
2019
Mar 31, 2018
$1.88B
Apr 24, 2019
Q3
2018
Sep 30, 2017
$1.86B
Oct 24, 2018
Q2
2018
Jun 30, 2017
$1.86B
Jul 25, 2018
Q1
2018
Mar 31, 2017
$1.82B
Apr 20, 2018
Q3
2017
Sep 30, 2016
$1.89B
Oct 19, 2017
Q2
2017
Jun 30, 2016
$1.91B
Jul 25, 2017
Q1
2017
Mar 31, 2016
$1.86B
Apr 21, 2017
Q3
2016
Sep 30, 2015
$1.88B
Oct 21, 2016
Q2
2016
Jun 30, 2015
$1.93B
Jul 25, 2016
Q1
2016
Mar 31, 2015
$1.84B
Apr 27, 2016
Q3
2015
Sep 30, 2014
$1.90B
Oct 29, 2015
Q2
2015
Jun 30, 2014
$1.90B
Jul 30, 2015
Q1
2015
Mar 31, 2014
$1.75B
Apr 30, 2015
Q3
2014
Sep 30, 2013
$1.79B
Oct 30, 2014
Q2
2014
Jun 30, 2013
$1.82B
Jul 31, 2014
Q1
2014
Mar 31, 2013
$1.79B
May 1, 2014
Q3
2013
Sep 30, 2012
$1.82B
Oct 24, 2013
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$245.00M
Oct 21, 2025
Q2
2025
Jun 30, 2025
$282.00M
Jul 23, 2025
Q1
2025
Mar 31, 2025
$220.00M
Apr 23, 2025
Q3
2025
Sep 30, 2024
$226.00M
Oct 21, 2025
Q2
2025
Jun 30, 2024
$229.00M
Jul 23, 2025
Q1
2025
Mar 31, 2024
$194.00M
Apr 23, 2025
Q3
2024
Sep 30, 2023
$225.00M
Oct 23, 2024
Q2
2024
Jun 30, 2023
$235.00M
Jul 24, 2024
Q1
2024
Mar 31, 2023
$202.00M
Apr 24, 2024
Q3
2023
Sep 30, 2022
$256.00M
Oct 25, 2023
Q2
2023
Jun 30, 2022
$234.00M
Jul 27, 2023
Q1
2023
Mar 31, 2022
$355.00M
Apr 28, 2023
Q3
2022
Sep 30, 2021
$505.00M
Oct 21, 2022
Q2
2022
Jun 30, 2021
$631.00M
Jul 22, 2022
Q1
2022
Mar 31, 2021
$469.00M
Apr 22, 2022
Q3
2021
Sep 30, 2020
$568.00M
Oct 22, 2021
Q2
2021
Jun 30, 2020
$185.00M
Jul 23, 2021
Q1
2021
Mar 31, 2020
$99.00M
Apr 23, 2021
Q3
2020
Sep 30, 2019
$215.00M
Oct 23, 2020
Q2
2020
Jun 30, 2019
$226.00M
Jul 24, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$386.00M
Oct 21, 2025
Q2
2025
Jun 30, 2025
$438.00M
Jul 23, 2025
Q1
2025
Mar 31, 2025
$346.00M
Apr 23, 2025
Q3
2025
Sep 30, 2024
$330.00M
Oct 21, 2025
Q2
2025
Jun 30, 2024
$355.00M
Jul 23, 2025
Q1
2025
Mar 31, 2024
$300.00M
Apr 23, 2025
Q3
2024
Sep 30, 2023
$342.00M
Oct 23, 2024
Q2
2024
Jun 30, 2023
$348.00M
Jul 24, 2024
Q1
2024
Mar 31, 2023
$305.00M
Apr 24, 2024
Q3
2023
Sep 30, 2022
$392.00M
Oct 25, 2023
Q2
2023
Jun 30, 2022
$388.00M
Jul 27, 2023
Q1
2023
Mar 31, 2022
$513.00M
Apr 28, 2023
Q3
2022
Sep 30, 2021
$652.00M
Oct 21, 2022
Q2
2022
Jun 30, 2021
$533.00M
Jul 22, 2022
Q1
2022
Mar 31, 2021
$660.00M
Apr 22, 2022
Q3
2021
Sep 30, 2020
$718.00M
Oct 22, 2021
Q2
2021
Jun 30, 2020
$283.00M
Jul 23, 2021
Q1
2021
Mar 31, 2020
$175.00M
Apr 23, 2021
Q3
2020
Sep 30, 2019
$313.00M
Oct 23, 2020
Q2
2020
Jun 30, 2019
$307.00M
Jul 24, 2020